S, L. L., C, B., M, B., A, C., F, C., L, M., . . . J, D. (2026). Neurofilament as a biomarker of neurodegeneration in childhood Langerhans cell histiocytosis: A feasibility study on 273 patients. British journal of haematology, 208(6), 2113. https://doi.org/10.1111/bjh.70466
Chicago Style (17th ed.) CitationS, Le Louet, et al. "Neurofilament as a Biomarker of Neurodegeneration in Childhood Langerhans Cell Histiocytosis: A Feasibility Study on 273 Patients." British Journal of Haematology 208, no. 6 (2026): 2113. https://doi.org/10.1111/bjh.70466.
MLA (9th ed.) CitationS, Le Louet, et al. "Neurofilament as a Biomarker of Neurodegeneration in Childhood Langerhans Cell Histiocytosis: A Feasibility Study on 273 Patients." British Journal of Haematology, vol. 208, no. 6, 2026, p. 2113, https://doi.org/10.1111/bjh.70466.